Circulating Tumor Cells - Global Market Outlook (2015-2022)

Circulating Tumor Cells - Global Market Outlook (2015-2022)

  • Published: March 2016
  • ID: SMRC15613

According to Stratistics MRC, the Global Circulating Tumor Cells Market is accounted at $4.41 billion in 2015 and is expected to reach $17.96 billion by 2022 growing at a CAGR of 19.2 % from 2015 to 2022. The rising demand for high Benefit-Cost Ratio (BCR) associated with CTCs prognostic technology is the major factor boosting the market growth. Furthermore, advancements in biomedical imaging and bioengineering technology are some of the key factors driving the market. However, high cost associated with the diagnosing and reluctance among people towards adopting highly developed prognostic technologies inhibit the market growth. The recent trends in global Circulating Tumor Cells are strengthening distribution network of CTCs prognostic technologies in emerging economies and the technical advancement of CTCs-based customized medicines.

Tumor cell detection is the foremost product segment primarily due to the advantages related with therapeutic monitoring and high procedure prices. North America region is expected to witness highest growth rate during the forecast period due to increasing demand in number of research projects. In addition, the U.S. Government also supports research by funding various institutes, which grant research funds.

Some of the key players in the market include Adnagen AG, Advanced Cell Diagnostics, Apocell, Aviva Biosciences, Biocep Ltd., Biocept Inc., Biofluidica, Canopus Biosciences, CellTraffix Inc., Clearbridge BioMedics, Creatv Microtech Inc., Cynvenio Biosystems Inc. , Epic Biosciences, Fluxion Biosciences., Greiner Bio-One GmbH, Ikonisys Inc., IV Diagnostics Inc., Janssen Diagnostics, Miltenyi Biotech and Nanostring Technologies Inc.

Technologies Covered:
• Tumor Cell Enrichment
o Filtration
o Centrifugation
o Immunological and Immunomagnetic
• Tumor Cell Detection
o Molecular
o Optical

Applications Covered:
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain 
o Rest of Europe     
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific   
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary  
    
2 Preface
   
 2.1 Abstract  
 2.2 Stake Holders 
 2.3 Research Scope 
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources 
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
    
3 Market Trend Analysis 
 3.1 Introduction 
 3.2 Drivers  
 3.3 Restraints 
 3.4 Opportunities 
 3.5 Threats  
 3.6 Technology Analysis
 3.7 Application Analysis 
 3.8 Emerging Markets 
    
4 Porters Five Force Analysis 
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry 
    
5 Global Circulating Tumor Cells Market, By Technology
 5.1 Introduction 
 5.2 Tumor Cell Enrichment
  5.2.1 Filtration 
  5.2.2 Centrifugation
  5.2.3 Immunological and Immunomagnetic
 5.3 Tumor Cell Detection
  5.3.1 Molecular
  5.3.2 Optical 
    
6 Global Circulating Tumor Cells Market, By Applications
 6.1 Introduction 
 6.2 Breast Cancer 
 6.3 Colorectal Cancer 
 6.4 Prostate Cancer 
 6.5 Other Applications 
    
7 Global Circulating Tumor Cells Market, By Geography
 7.1 North America 
  7.1.1 US 
  7.1.2 Canada 
  7.1.3 Mexico 
 7.2 Europe  
  7.2.1 Germany 
  7.2.2 France 
  7.2.3 Italy 
  7.2.4 UK 
  7.2.5 Spain 
  7.2.6 Rest of Europe
 7.3 Asia Pacific 
  7.3.1 Japan 
  7.3.2 China 
  7.3.3 India 
  7.3.4 Australia 
  7.3.5 New Zealand
  7.3.6 Rest of Asia Pacific
 7.4 Rest of the World 
  7.4.1 Middle East
  7.4.2 Brazil 
  7.4.3 Argentina
  7.4.4 South Africa
  7.4.5 Egypt 
    
8 Key Developments  
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
 8.2 Acquisitions & Mergers
 8.3 New Product Launch
 8.4 Expansions 
 8.5 Other Key Strategies
    
9 Company Profiling  
 9.1 Adnagen AG 
 9.2 Advanced Cell Diagnostics
 9.3 Apocell  
 9.4 Aviva Biosciences 
 9.5 Biocep Ltd. 
 9.6 Biocept Inc. 
 9.7 Biofluidica 
 9.8 Canopus Biosciences
 9.9 CellTraffix Inc. 
 9.10 Clearbridge BioMedics
 9.11 Creatv Microtech Inc.
 9.12 Cynvenio Biosystems Inc. 
 9.13 Epic Biosciences 
 9.14 Fluxion Biosciences.
 9.15 Greiner Bio-One GmbH
 9.16 Ikonisys Inc. 
 9.17 IV Diagnostics Inc. 
 9.18 Janssen Diagnostics 
 9.19 Miltenyi Biotech 
 9.20 Nanostring Technologies Inc. 


List of Tables   
1 Global Circulating Tumor Cells Market Outlook, By Region (2015-2022) ($MN)
2 Global Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
3 Global Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
4 Global Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
6 Global Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
7 Global Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
8 Global Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
9 Global Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
10 Global Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
11 North America Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
12 North America Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
13 North America Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
14 North America Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
15 North America Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
16 North America Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
18 North America Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
19 North America Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
20 Europe Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
21 Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
22 Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
23 Europe Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
24 Europe Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
25 Europe Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
26 Europe Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
27 Europe Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
28 Aisa Pacific Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
29 Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
30 Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
31 Aisa Pacific Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
32 Aisa Pacific Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
34 Aisa Pacific Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
35 Aisa Pacific Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
36 Aisa Pacific Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
37 Rest of the World Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
38 Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
39 Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
40 Rest of the World Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
41 Rest of the World Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
42 Rest of the World Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
43 Rest of the World Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
44 Rest of the World Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials